Publications - The Tumour Marker Group

Publications 2023

Bitter H, Warren DJ, Bolstad N, Noraas AL, Ostensen ME (2023)
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
Ann Rheum Dis, 82 (4), 577-579
DOI 10.1136/ard-2022-223684, PubMed 36604152

Brun MK, Bjørlykke KH, Viken MK, Stenvik GE, Klaasen RA, Gehin JE, Warren DJ, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Haavardsholm EA, Jahnsen J, Goll GL, Lie BA, Bolstad N, Jørgensen KK, Syversen SW (2023)
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
J Intern Med, 293 (5), 648-655
DOI 10.1111/joim.13616, PubMed 36843323

Jyssum I, Gehin JE, Sexton J, Kristianslund EK, Hu Y, Warren DJ, Kvien TK, Haavardsholm EA, Syversen SW, Bolstad N, Goll GL (2023)
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead525, PubMed 37773994

Jørgensen KK, Høivik ML, Chopra A, Benth JŠ, Ricanek P, Moum PB, Jyssum I, Bolstad N, Warren DJ, Vaage PJT, Munthe PLA, Lundin PKEA, Anisdahl K, Syversen SW, Goll GL, Lund-Johansen F, Medhus AW, Jahnsen PJ (2023)
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type
Scand J Gastroenterol, 58 (8), 874-882
DOI 10.1080/00365521.2023.2177884, PubMed 36788656

Nome RV, Amundsen EK, Tvedt THA, Fenstad MH, Øie E (2023)
[How often should blood tests be repeated?]
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.22.0658, PubMed 36655958

Syversen SW, Gehin JE, Goll GL, Bolstad N, Haavardsholm EA, Lillegraven S (2023)
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases
Arthritis Rheumatol (in press)
DOI 10.1002/art.42764, PubMed 37984460

Wammer ACP, Nermoen I, Medbøe Thorsby P, Bolstad N, Lima K, Tran H, Følling I (2023)
Insulin autoimmune syndrome: not just one but two different diseases with therapeutic implications
Endocrinol Diabetes Metab Case Rep, 2023 (4)
DOI 10.1530/EDM-23-0032, PubMed 37988766

Wiken TH, Høivik ML, Buer L, Warren DJ, Bolstad N, Moum BA, Anisdahl K, Småstuen MC, Medhus AW (2023)
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
Scand J Gastroenterol, 58 (8), 863-873
DOI 10.1080/00365521.2023.2176252, PubMed 36799155

Publications 2022

Alver TN, Heintz KM, Hovig E, Bøe SL (2022)
Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway
Cancer Rep (Hoboken), 6 (2), e1736
DOI 10.1002/cnr2.1736, PubMed 36251678

Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S, Haavardsholm EA, Grødeland G, Provan SA, Vaage JT, Syversen SW, Goll GL, Jørgensen KK (2022)
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Lancet Rheumatol, 5 (1), e36-e46
DOI 10.1016/S2665-9913(22)00330-7, PubMed 36415604

Brun MK, Goll GL, Jørgensen KK, Sexton J, Gehin JE, Sandanger Ø, Olsen IC, Klaasen RA, Warren DJ, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA, Syversen SW (2022)
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
J Intern Med, 292 (3), 477-491
DOI 10.1111/joim.13495, PubMed 35411981

Christensen IE, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, Kro GB, Kvien TK, Warren DJ, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Grødeland G, Lund-Johansen F, Jørgensen KK, Syversen SW, Goll GL, Provan SA (2022)
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
BMC Med, 20 (1), 378
DOI 10.1186/s12916-022-02587-8, PubMed 36199139

Dorn-Rasmussen M, Buhl S, Brynskov J, Bay JT, Bolstad N, Klausen TW, Warren DJ, Ainsworth MA, Steenholdt C (2022)
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease
Ther Drug Monit, 44 (2), 290-300
DOI 10.1097/FTD.0000000000000913, PubMed 34387220

Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
J Clin Endocrinol Metab, 107 (5), e2141-e2147
DOI 10.1210/clinem/dgab907, PubMed 34922379

Gehin JE, Goll GL, Brun MK, Jani M, Bolstad N, Syversen SW (2022)
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine
BioDrugs, 36 (6), 731-748
DOI 10.1007/s40259-022-00559-1, PubMed 36315391

Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
J Cancer Surviv, 17 (4), 1082-1093
DOI 10.1007/s11764-022-01273-1, PubMed 36350483

Klaasen RA, Warren DJ, Iversen R, Bolstad N, Andersen IL, Mjønes P, Rønne E, Lundin KEA, Sollid LM, Ness-Jensen E (2022)
The development and validation of a high-capacity serological assay for celiac disease
Clin Biochem, 107, 13-18
DOI 10.1016/j.clinbiochem.2022.05.010, PubMed 35660483

Krieckaert C, Hernández-Breijo B, Gehin JE, le Mélédo G, Balsa A, Jani M, Mulleman D, Navarro-Compan V, Wolbink G, Isaac J, van Tubergen A (2022)
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
RMD Open, 8 (2)
DOI 10.1136/rmdopen-2022-002216, PubMed 35980738

Krieckaert CL, van Tubergen A, Gehin JE, Hernández-Breijo B, Le Mélédo G, Balsa A, Böhm P, Cucnik S, Elkayam O, Goll GL, Hooijberg F, Jani M, Kiely PD, McCarthy N, Mulleman D, Navarro-Compán V, Payne K, Perry ME, Plasencia-Rodriguez C, Stones SR, Syversen SW, de Vries A, Ward KM, Wolbink G, Isaacs JD (2022)
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Ann Rheum Dis, 82 (1), 65-73
DOI 10.1136/annrheumdis-2022-222155, PubMed 35551063

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554

Syversen SW, Jyssum I, Tveter AT, Sexton J, Christensen IE, Tran TT, Bjørlykke KH, Mjaaland S, Warren DJ, Kvien TK, Chopra A, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Jørgensen KK, Goll GL (2022)
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
RMD Open, 8 (2)
DOI 10.1136/rmdopen-2022-002417, PubMed 36328399

Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ, Kvien TK, Grødeland G, Nissen-Meyer LSH, Ricanek P, Chopra A, Andersson AM, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Lund-Johansen F, Jørgensen KK, Goll GL (2022)
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Arthritis Rheumatol, 74 (8), 1321-1332
DOI 10.1002/art.42153, PubMed 35507355

Publications 2021

Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
DOI 10.1093/ehjci/jeaa289, PubMed 33152065

Gehin JE, Klaasen RA, Norli ES, Warren DJ, Syversen SW, Goll GL, Bjøro T, Kvien TK, Mjaavatten MD, Bolstad N (2021)
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
Rheumatol Int, 41 (9), 1657-1665
DOI 10.1007/s00296-021-04865-9, PubMed 33944985

Gehin JE, Syversen SW, Warren DJ, Goll GL, Sexton J, Bolstad N, Hammer HB (2021)
Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis
RMD Open, 7 (3)
DOI 10.1136/rmdopen-2021-001985, PubMed 34911811

Gehin JE, Warren DJ, Syversen SW, Lie E, Sexton J, Loli L, Wierød A, Bjøro T, Kvien TK, Bolstad N, Goll GL (2021)
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
Scand J Rheumatol, 50 (6), 445-454
DOI 10.1080/03009742.2021.1875040, PubMed 33650469

Grišić AM, Dorn-Rasmussen M, Ungar B, Brynskov J, Ilvemark JFKF, Bolstad N, Warren DJ, Ainsworth MA, Huisinga W, Ben-Horin S, Kloft C, Steenholdt C (2021)
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
United European Gastroenterol J, 9 (1), 91-101
DOI 10.1177/2050640620964619, PubMed 33079627

Hernández-Breijo B, Navarro-Compán V, Plasencia-Rodríguez C, Parodis I, Gehin JE, Martínez-Feito A, Novella-Navarro M, Mezcua A, Warren DJ, Nozal P, Pascual-Salcedo D, Balsa A (2021)
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Sci Rep, 11 (1), 11632
DOI 10.1038/s41598-021-91177-4, PubMed 34079038

Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, Jørgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Grødeland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL (2021)
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
Lancet Rheumatol, 4 (3), e177-e187
DOI 10.1016/S2665-9913(21)00394-5, PubMed 34977602

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829

Syversen SW, Bolstad N, Haavardsholm EA (2021)
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply
JAMA, 326 (11), 1069-1070
DOI 10.1001/jama.2021.11480, PubMed 34546304

Syversen SW, Goll GL, Jørgensen KK, Sandanger Ø, Sexton J, Olsen IC, Gehin JE, Warren DJ, Brun MK, Klaasen RA, Karlsen LN, Noraberg G, Zettel C, Ljoså MKA, Haugen AJ, Njålla RJ, Bruun TJ, Seeberg KA, Michelsen B, Strand EK, Skorpe S, Blomgren IM, Bragnes YH, Dotterud CK, Thune T et al. (2021)
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 325 (17), 1744-1754
DOI 10.1001/jama.2021.4172, PubMed 33944876

Syversen SW, Jørgensen KK, Goll GL, Brun MK, Sandanger Ø, Bjørlykke KH, Sexton J, Olsen IC, Gehin JE, Warren DJ, Klaasen RA, Noraberg G, Bruun TJ, Dotterud CK, Ljoså MKA, Haugen AJ, Njålla RJ, Zettel C, Ystrøm CM, Bragnes YH, Skorpe S, Thune T, Seeberg KA, Michelsen B, Blomgren IM et al. (2021)
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 326 (23), 2375-2384
DOI 10.1001/jama.2021.21316, PubMed 34932077

Publications 2020

Buhl S, Dorn-Rasmussen M, Brynskov J, Ainsworth MA, Bendtzen K, Klausen PH, Bolstad N, Warren DJ, Steenholdt C (2020)
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease
Scand J Gastroenterol, 55 (8), 884-890
DOI 10.1080/00365521.2020.1786852, PubMed 32631131

Fosså SD, Dahl AA, Myklebust TÅ, Kiserud CE, Nome R, Klepp OH, Brydøy M, Haugnes HS (2020)
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Cancer Epidemiol, 67, 101744
DOI 10.1016/j.canep.2020.101744, PubMed 32652337

Gjefsen E, Bråten LCH, Goll GL, Wigemyr M, Bolstad N, Valberg M, Schistad EI, Marchand GH, Granviken F, Selmer KK, Froholdt A, Haugen AJ, Dagestad MH, Vetti N, Bakland G, Lie BA, Haavardsholm EA, Nilsen AT, Holmgard TE, Kadar TI, Kvien T, Skouen JS, Grøvle L, Brox JI, Espeland A et al. (2020)
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial
BMC Musculoskelet Disord, 21 (1), 698
DOI 10.1186/s12891-020-03720-5, PubMed 33087100

Hager HB, Bolstad N, Warren DJ, Ness MV, Seierstad B, Lindberg M (2020)
Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies
Clin Chem Lab Med, 59 (4), 663-669
DOI 10.1515/cclm-2020-1411, PubMed 33119540

Jørgensen KK, Goll GL, Sexton J, Bolstad N, Olsen IC, Asak Ø, Berset IP, Blomgren IM, Dvergsnes K, Florholmen J, Frigstad SO, Henriksen M, Hagfors J, Huppertz-Hauss G, Haavardsholm EA, Klaasen RA, Moum B, Noraberg G, Prestegård U, Rydning JH, Sagatun L, Seeberg KA, Torp R, Vold C, Warren DJ et al. (2020)
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
BioDrugs, 34 (5), 681-694
DOI 10.1007/s40259-020-00438-7, PubMed 32965617

Kolstad A, Illidge T, Bolstad N, Spetalen S, Madsbu U, Stokke C, Blakkisrud J, Løndalen A, O'Rourke N, Beasley M, Jurczak W, Fagerli UM, Kaščák M, Bayne M, Obr A, Dahle J, Rojkjaer L, Pascal V, Holte H (2020)
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Blood Adv, 4 (17), 4091-4101
DOI 10.1182/bloodadvances.2020002583, PubMed 32877524

Lavelle TJ, Alver TN, Heintz KM, Wernhoff P, Nygaard V, Nakken S, Øy GF, Bøe SL, Urbanucci A, Hovig E (2020)
Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes
Cancers (Basel), 12 (7)
DOI 10.3390/cancers12071719, PubMed 32605315

Levernæs MCS, Moe AU, Bøe SL, Paus E, Reubsaet L, Halvorsen TG (2020)
Liquid chromatography mass spectrometry based characterization of epitope configurations
Anal Methods, 12 (45), 5476-5484
DOI 10.1039/d0ay01283a, PubMed 33141131

Mitlid-Mork B, Bowe S, Gran JM, Bolstad N, Berg JP, Redman CW, Staff AC, Sugulle M (2020)
Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study
PLoS One, 15 (10), e0240473
DOI 10.1371/journal.pone.0240473, PubMed 33079955

Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD (2020)
Longitudinal kidney function outcome in aging testicular cancer survivors
Acta Oncol, 59 (4), 467-474
DOI 10.1080/0284186X.2020.1724328, PubMed 32043400

Randel KR, Schult AL, Botteri E, Hoff G, Bretthauer M, Ursin G, Natvig E, Berstad P, Jørgensen A, Sandvei PK, Olsen ME, Frigstad SO, Darre-Næss O, Norvard ER, Bolstad N, Kørner H, Wibe A, Wensaas KA, de Lange T, Holme Ø (2020)
Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial
Gastroenterology, 160 (4), 1085-1096.e5
DOI 10.1053/j.gastro.2020.11.037, PubMed 33227280

Salminen L, Nadeem N, Rolfsen AL, Dørum A, Laajala TD, Grènman S, Hietanen S, Heinosalo T, Perheentupa A, Poutanen M, Bolstad N, Carpén O, Lamminmäki U, Pettersson K, Gidwani K, Hynninen J, Huhtinen K (2020)
Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses
J Appl Lab Med, 5 (2), 263-272
DOI 10.1093/jalm/jfz012, PubMed 32445385

Syversen SW, Goll GL, Jørgensen KK, Olsen IC, Sandanger Ø, Gehin JE, Warren DJ, Sexton J, Mørk C, Jahnsen J, Kvien TK, Bolstad N, Haavardsholm EA (2020)
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Trials, 21 (1), 13
DOI 10.1186/s13063-019-3734-4, PubMed 31907007

Waaler J, Mygland L, Tveita A, Strand MF, Solberg NT, Olsen PA, Aizenshtadt A, Fauskanger M, Lund K, Brinch SA, Lycke M, Dybing E, Nygaard V, Bøe SL, Heintz KM, Hovig E, Hammarström C, Corthay A, Krauss S (2020)
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
Commun Biol, 3 (1), 196
DOI 10.1038/s42003-020-0916-2, PubMed 32332858

Yang M, Lin X, Segers F, Suganthan R, Hildrestrand GA, Rinholm JE, Aas PA, Sousa MML, Holm S, Bolstad N, Warren D, Berge RK, Johansen RF, Yndestad A, Kristiansen E, Klungland A, Luna L, Eide L, Halvorsen B, Aukrust P, Bjørås M (2020)
OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation
Cell Rep, 30 (12), 4165-4178.e7
DOI 10.1016/j.celrep.2020.02.063, PubMed 32209476

Publications 2019

Buer LCT, Moum BA, Cvancarova M, Warren DJ, Bolstad N, Medhus AW, Høivik ML (2019)
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
Scand J Gastroenterol, 54 (1), 41-48
DOI 10.1080/00365521.2018.1548646, PubMed 30650312

Carlsen A, Omdal R, Karlsen L, Kvaløy JT, Aabakken L, Steinsbø Ø, Bolstad N, Warren D, Lundin KEA, Grimstad T (2019)
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease
JGH Open, 4 (3), 410-416
DOI 10.1002/jgh3.12266, PubMed 32514446

Gehin JE, Goll GL, Warren DJ, Syversen SW, Sexton J, Strand EK, Kvien TK, Bolstad N, Lie E (2019)
Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study
Arthritis Res Ther, 21 (1), 256
DOI 10.1186/s13075-019-2009-5, PubMed 31783773

Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G et al. (2019)
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
J Intern Med, 285 (6), 653-669
DOI 10.1111/joim.12880, PubMed 30762274

Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
Ther Drug Monit, 41 (1), 11-18
DOI 10.1097/FTD.0000000000000580, PubMed 30633722

Köksal H, Baken E, Warren DJ, Løset GÅ, Inderberg EM, Wälchli S (2019)
Chimeric antigen receptor preparation from hybridoma to T-cell expression
Antib Ther, 2 (2), 56-63
DOI 10.1093/abt/tbz007, PubMed 33928223

Meuwese CL, van Diepen M, Cappola AR, Sarnak MJ, Shlipak MG, Bauer DC, Fried LP, Iacoviello M, Vaes B, Degryse J, Khaw KT, Luben RN, Åsvold BO, Bjøro T, Vatten LJ, de Craen AJM, Trompet S, Iervasi G, Molinaro S, Ceresini G, Ferrucci L, Dullaart RPF, Bakker SJL, Jukema JW, Kearney PM et al. (2019)
Low thyroid function is not associated with an accelerated deterioration in renal function
Nephrol Dial Transplant, 34 (4), 650-659
DOI 10.1093/ndt/gfy071, PubMed 29684213

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
Eur Thyroid J, 8 (3), 159-166
DOI 10.1159/000499018, PubMed 31259158

Smeland HY, Askeland C, Wik E, Knutsvik G, Molven A, Edelmann RJ, Reed RK, Warren DJ, Gullberg D, Stuhr L, Akslen LA (2019)
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
J Pathol Clin Res, 6 (1), 69-82
DOI 10.1002/cjp2.148, PubMed 31605508

Publications 2018

Buer LCT, Høivik ML, Warren DJ, Medhus AW, Moum BA (2018)
Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series
Inflamm Bowel Dis, 24 (5), 997-1004
DOI 10.1093/ibd/izx110, PubMed 29668901

Carlsen A, Omdal R, Leitao KØ, Isaksen K, Hetta AK, Karlsen LN, Aabakken L, Bolstad N, Warren D, Lundin KEA, Grimstad T (2018)
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease
Therap Adv Gastroenterol, 11, 1756284818759930
DOI 10.1177/1756284818759930, PubMed 29623105

Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P (2018)
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
BMC Cancer, 18 (1), 68
DOI 10.1186/s12885-017-3948-3, PubMed 29321030

Glintborg B, Kringelbach T, Bolstad N, Warren DJ, Eng G, Sørensen IJ, Loft AG, Hendricks O, Hansen I, Linauskas A, Nordin H, Kristensen S, Lindegaard H, Jensen DV, Goll GL, Høgdall E, Gehin J, Enevold C, Nielsen CH, Krogh NS, Johansen JS, Hetland ML (2018)
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
Scand J Rheumatol, 47 (5), 418-421
DOI 10.1080/03009742.2017.1376110, PubMed 29310493

Høivik ML, Buer LCT, Cvancarova M, Warren DJ, Bolstad N, Moum BA, Medhus AW (2018)
Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population
Scand J Gastroenterol, 53 (6), 692-699
DOI 10.1080/00365521.2018.1463391, PubMed 29852793

Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
Ther Drug Monit, 40 (5), 558-566
DOI 10.1097/FTD.0000000000000539, PubMed 30086087

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
Eur Thyroid J, 8 (1), 31-40
DOI 10.1159/000493977, PubMed 30800639

Rieber-Mohn AB, Sugulle M, Wallukat G, Alnæs-Katjavivi P, Leite Størvold G, Bolstad N, Redman CW, Dechend R, Staff AC (2018)
Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum
J Reprod Immunol, 128, 23-29
DOI 10.1016/j.jri.2018.05.008, PubMed 29843114

Smeland KB, Loge JH, Aass HCD, Aspelin T, Bersvendsen H, Bolstad N, Fagerli UM, Falk RS, Fluge Ø, Fosså A, Holte H, Lund MB, Murbræch K, Reinertsen KV, Stenehjem JS, Kiserud CE (2018)
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
Bone Marrow Transplant, 54 (4), 607-610
DOI 10.1038/s41409-018-0342-y, PubMed 30262906

Thomsen M, Skovlund E, Sorbye H, Bolstad N, Nustad KJ, Glimelius B, Pfeiffer P, Kure EH, Johansen JS, Tveit KM, Christoffersen T, Guren TK (2018)
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
Br J Cancer, 118 (12), 1609-1616
DOI 10.1038/s41416-018-0115-9, PubMed 29872151

Ueland T, Gullestad L, Kou L, Aukrust P, Anand IS, Broughton MN, McMurray JJ, van Veldhuisen DJ, Warren DJ, Bolstad N (2018)
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
ESC Heart Fail, 5 (6), 1052-1059
DOI 10.1002/ehf2.12312, PubMed 30145817

Publications 2017

Bader LI, Solberg SM, Kaada SH, Bolstad N, Warren DJ, Gavasso S, Gjesdal CG, Vedeler CA (2017)
Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories
Scand J Immunol, 86 (3), 165-170
DOI 10.1111/sji.12572, PubMed 28561325

Broughton MN, Westgaard A, Paus E, Øijordsbakken M, Henanger KJ, Naume B, Bjøro T (2017)
Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
Tumour Biol, 39 (6), 1010428317707436
DOI 10.1177/1010428317707436, PubMed 28653892

Buer LC, Moum BA, Cvancarova M, Warren DJ, Medhus AW, Høivik ML (2017)
Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study
J Crohns Colitis, 11 (3), 297-304
DOI 10.1093/ecco-jcc/jjw166, PubMed 27660339

Hov KR, Bolstad N, Idland AV, Zetterberg H, Blennow K, Chaudhry FA, Frihagen F, Ræder J, Wyller TB, Watne LO (2017)
Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium
Dement Geriatr Cogn Dis Extra, 7 (3), 374-385
DOI 10.1159/000481853, PubMed 29282410

Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK, NOR-SWITCH study group (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Lancet, 389 (10086), 2304-2316
DOI 10.1016/S0140-6736(17)30068-5, PubMed 28502609

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N (2017)
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759

Salvador CL, Tøndel C, Rowe AD, Bjerre A, Brun A, Brackman D, Bolstad N, Mørkrid L (2017)
Renal Function Influences Diagnostic Markers in Serum and Urine: A Study of Guanidinoacetate, Creatine, Human Epididymis Protein 4, and Neutrophil Gelatinase-Associated Lipocalin in Children
J Appl Lab Med, 2 (3), 297-308
DOI 10.1373/jalm.2016.022145, PubMed 33636843

Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE (2017)
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
Acta Oncol, 56 (4), 590-598
DOI 10.1080/0284186X.2016.1267870, PubMed 28077016

Publications 2016

Halvorsen AR, Bjaanæs M, LeBlanc M, Holm AM, Bolstad N, Rubio L, Peñalver JC, Cervera J, Mojarrieta JC, López-Guerrero JA, Brustugun OT, Helland Å (2016)
A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer
Oncotarget, 7 (24), 37250-37259
DOI 10.18632/oncotarget.9363, PubMed 27191990

Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
Thyroid, 26 (9), 1225-38
DOI 10.1089/thy.2015.0673, PubMed 27400880

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE (2016)
Fatigue During and After Breast Cancer Therapy-A Prospective Study
J Pain Symptom Manage, 53 (3), 551-560
DOI 10.1016/j.jpainsymman.2016.09.011, PubMed 28042070

Aakre I, Strand TA, Bjøro T, Norheim I, Barikmo I, Ares S, Alcorta MD, Henjum S (2016)
Thyroid Function among Breastfed Children with Chronically Excessive Iodine Intakes
Nutrients, 8 (7)
DOI 10.3390/nu8070398, PubMed 27367720

Publications 2015

Benterud T, Pankratov L, Solberg R, Bolstad N, Skinningsrud A, Baumbusch L, Sandvik L, Saugstad OD (2015)
Perinatal Asphyxia May Influence the Level of Beta-Amyloid (1-42) in Cerebrospinal Fluid: An Experimental Study on Newborn Pigs
PLoS One, 10 (10), e0140966
DOI 10.1371/journal.pone.0140966, PubMed 26501201

Broughton MN, Nome R, Sandven I, Paus E, Bjøro T (2015)
Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies
Tumour Biol, 37 (6), 7729-39
DOI 10.1007/s13277-015-4597-2, PubMed 26695140

Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO (2015)
Prevalence of Thyroid Dysfunction in Autoimmune and Type 2 Diabetes: The Population-Based HUNT Study in Norway
J Clin Endocrinol Metab, 101 (2), 669-77
DOI 10.1210/jc.2015-3235, PubMed 26583583

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L (2015)
HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank
Int J Gynecol Cancer, 25 (9), 1608-15
DOI 10.1097/IGC.0000000000000532, PubMed 26501436

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
DOI 10.1007/s11764-015-0439-x, PubMed 25750158

Sprauten M, Haugnes HS, Brydøy M, Kiserud C, Tandstad T, Bjøro T, Bjerner J, Cvancarova M, Fosså SD, Oldenburg J (2015)
Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors
Ann Oncol, 26 (10), 2133-40
DOI 10.1093/annonc/mdv328, PubMed 26265167

Aakre I, Bjøro T, Norheim I, Strand TA, Barikmo I, Henjum S (2015)
Development of thyroid dysfunction among women with excessive iodine intake--A 3-year follow-up
J Trace Elem Med Biol, 31, 61-6
DOI 10.1016/j.jtemb.2015.03.004, PubMed 26004893

Åsvold BO, Vatten LJ, Bjøro T, Bauer DC, Bremner A, Cappola AR, Ceresini G, den Elzen WP, Ferrucci L, Franco OH, Franklyn JA, Gussekloo J, Iervasi G, Imaizumi M, Kearney PM, Khaw KT, Maciel RM, Newman AB, Peeters RP, Psaty BM, Razvi S, Sgarbi JA, Stott DJ, Trompet S, Vanderpump MP et al. (2015)
Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts
JAMA Intern Med, 175 (6), 1037-47
DOI 10.1001/jamainternmed.2015.0930, PubMed 25893284

Publications 2014

Brauckhoff M, Machens A, Lorenz K, Bjøro T, Varhaug JE, Dralle H (2014)
Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective
Ann Surg, 259 (4), 800-6
DOI 10.1097/SLA.0b013e3182a6f43a, PubMed 23979292

Kiserud CE, Seland M, Holte H, Fosså A, Fosså SD, Bollerslev J, Bjøro T, Loge JH (2014)
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862

Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, Fosså SD, Oldenburg J (2014)
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125

Aakre I, Bjøro T, Norheim I, Strand TA, Barikmo I, Henjum S (2014)
Excessive iodine intake and thyroid dysfunction among lactating Saharawi women
J Trace Elem Med Biol, 31, 279-84
DOI 10.1016/j.jtemb.2014.09.009, PubMed 25447589

Publications 2013

Asvold BO, Bjøro T, Vatten LJ (2013)
Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study
Eur J Endocrinol, 169 (1), 73-82
DOI 10.1530/EJE-13-0087, PubMed 23641017

Asvold BO, Vatten LJ, Bjøro T (2013)
Changes in the prevalence of hypothyroidism: the HUNT Study in Norway
Eur J Endocrinol, 169 (5), 613-20
DOI 10.1530/EJE-13-0459, PubMed 23975540

Bolstad N, Warren DJ, Nustad K (2013)
Heterophilic antibody interference in immunometric assays
Best Pract Res Clin Endocrinol Metab, 27 (5), 647-61
DOI 10.1016/j.beem.2013.05.011, PubMed 24094636

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ (2013)
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
Mod Pathol, 26 (4), 613-5
DOI 10.1038/modpathol.2013.39, PubMed 23542526

Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjøro T, Langhammer A (2013)
Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway
Eur J Endocrinol, 169 (6), 845-52
DOI 10.1530/EJE-13-0546, PubMed 24031093

Publications 2012

Asvold BO, Bjøro T, Platou C, Vatten LJ (2012)
Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway
Clin Endocrinol (Oxf), 77 (6), 911-7
DOI 10.1111/j.1365-2265.2012.04477.x, PubMed 22724581

Bjerner J, Bolstad N, Piehler A (2012)
Belief is only half the truth--or why screening for heterophilic antibody interference in certain assays makes double sense
Ann Clin Biochem, 49 (Pt 4), 381-6
DOI 10.1258/acb.2012.011228, PubMed 22740684

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2012)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera (vol 49, pg 2001, 2011)
Clin. Chem. Lab. Med., 50 (2), 409
DOI 10.1515/cclm-2012-0038

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Celestino R, Sigstad E, Løvf M, Thomassen GO, Grøholt KK, Jørgensen LH, Berner A, Castro P, Lothe RA, Bjøro T, Sobrinho-Simões M, Soares P, Skotheim RI (2012)
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
Genes Chromosomes Cancer, 51 (12), 1154-64
DOI 10.1002/gcc.22003, PubMed 22961909

Ekstrøm PO, Warren DJ, Thilly WG (2012)
Separation principles of cycling temperature capillary electrophoresis
Electrophoresis, 33 (7), 1162-8
DOI 10.1002/elps.201100550, PubMed 22539319

Nordlund MS, Stieber P, Brustugun OT, Warren DJ, Paus E (2012)
Characteristics and clinical validity of two immunoassays for ProGRP
Tumour Biol, 33 (4), 1105-13
DOI 10.1007/s13277-012-0351-1, PubMed 22399443

Rawal R, Teumer A, Völzke H, Wallaschofski H, Ittermann T, Åsvold BO, Bjøro T, Greiser KH, Tiller D, Werdan K, Meyer zu Schwabedissen HE, Doering A, Illig T, Gieger C, Meisinger C, Homuth G (2012)
Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function
Hum Mol Genet, 21 (14), 3275-82
DOI 10.1093/hmg/dds136, PubMed 22494929

Sachse D, Bolstad N, Jonsson M, Sæves I, Johansson CB, Delezuch W, Hagve M, Hardang IM, Isaksson HS, Ivarsson A, Lehto L, Keikkala E, Mattsson N, Ranta JK, Stavelin A, Sudmann AA, Varsi K (2012)
The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients
Scand J Clin Lab Invest, 72 (5), 374-9
DOI 10.3109/00365513.2012.677544, PubMed 22900743

Publications 2011

Bogsrud TV, Hay ID, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Lowe VJ (2011)
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies
Nucl Med Commun, 32 (4), 245-51
DOI 10.1097/MNM.0b013e328343a742, PubMed 21278616

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2011)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Clin Chem Lab Med, 49 (12), 2001-6
DOI 10.1515/CCLM.2011.702, PubMed 21899496

Bolstad N, Øijordsbakken M, Nustad K, Bjerner J (2011)
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Tumour Biol, 33 (1), 141-8
DOI 10.1007/s13277-011-0256-4, PubMed 22105734

Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, Bjøro T, Jørgensen LH (2011)
Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma
J Clin Endocrinol Metab, 96 (9), 2750-5
DOI 10.1210/jc.2010-2952, PubMed 21715533

Haakensen VD, Bjøro T, Lüders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Børresen-Dale AL, Helland Å (2011)
Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
BMC Cancer, 11, 332
DOI 10.1186/1471-2407-11-332, PubMed 21812955

Paus E, Hirzel K, Lidqvist M, Höyhtyä M, Warren DJ (2011)
TD-12 workshop report: characterization of monoclonal antibodies to neuron-specific enolase
Tumour Biol, 32 (4), 819-29
DOI 10.1007/s13277-011-0184-3, PubMed 21573737

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ (2011)
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors
Mod Pathol, 25 (4), 537-47
DOI 10.1038/modpathol.2011.188, PubMed 22157935

Svare A, Nilsen TI, Bjøro T, Asvold BO, Langhammer A (2011)
Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway
Clin Endocrinol (Oxf), 74 (6), 769-75
DOI 10.1111/j.1365-2265.2011.04009.x, PubMed 21521278

Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
Scand J Immunol, 74 (6), 632-9
DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353

Warren DJ (2011)
Preparation of highly efficient electrocompetent Escherichia coli using glycerol/mannitol density step centrifugation
Anal Biochem, 413 (2), 206-7
DOI 10.1016/j.ab.2011.02.036, PubMed 21362398

Åsvold BO, Vatten LJ, Midthjell K, Bjøro T (2011)
Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway
J Clin Endocrinol Metab, 97 (1), 93-9
DOI 10.1210/jc.2011-1724, PubMed 22049180

Publications 2010

Asvold BO, Bjøro T, Vatten LJ (2010)
Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study
Eur J Endocrinol, 164 (1), 101-5
DOI 10.1530/EJE-10-0705, PubMed 20930062

Publications 2009

Asvold BO, Bjøro T, Vatten LJ (2009)
Association of serum TSH with high body mass differs between smokers and never-smokers
J Clin Endocrinol Metab, 94 (12), 5023-7
DOI 10.1210/jc.2009-1180, PubMed 19846737

Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
Prostate Cancer Prostatic Dis, 12 (3), 269-76
DOI 10.1038/pcan.2009.8, PubMed 19290019

Bjerner J, Biernat D, Fosså SD, Bjøro T (2009)
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
DOI 10.3109/00365510903380886, PubMed 19929279

Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Hay ID, Lowe VJ (2009)
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma
Mol Imaging Biol, 12 (5), 547-53
DOI 10.1007/s11307-009-0276-2, PubMed 19949985

Hellevik AI, Asvold BO, Bjøro T, Romundstad PR, Nilsen TI, Vatten LJ (2009)
Thyroid function and cancer risk: a prospective population study
Cancer Epidemiol Biomarkers Prev, 18 (2), 570-4
DOI 10.1158/1055-9965.EPI-08-0911, PubMed 19155436

Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, Fosså SD (2009)
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
Br J Cancer, 100 (3), 455-63
DOI 10.1038/sj.bjc.6604892, PubMed 19156143

Kiserud CE, Schover LR, Dahl AA, Fosså A, Bjøro T, Loge JH, Holte H, Yuan Y, Fosså SD (2009)
Do male lymphoma survivors have impaired sexual function?
J Clin Oncol, 27 (35), 6019-26
DOI 10.1200/JCO.2009.23.2280, PubMed 19858388

Nordlund MS, Warren DJ, Laerdahl JK, Paus E (2009)
Studies on multiple forms of proGRP in serum from small cell lung cancer patients
Tumour Biol, 30 (5-6), 265-75
DOI 10.1159/000258135, PubMed 19907206

Nustad K, Nilsson O, Majnesjö K, Murakami A, Sugino N, Warren DJ, Kato H (2009)
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the second TD-10 workshop
Tumour Biol, 30 (1), 26-36
DOI 10.1159/000199448, PubMed 19194112

Panicker V, Evans J, Bjøro T, Asvold BO, Dayan CM, Bjerkeset O (2009)
A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study
Clin Endocrinol (Oxf), 71 (4), 574-80
DOI 10.1111/j.1365-2265.2008.03521.x, PubMed 19751298

Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332

Svare A, Nilsen TI, Bjøro T, Forsmo S, Schei B, Langhammer A (2009)
Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study
Eur J Endocrinol, 161 (5), 779-86
DOI 10.1530/EJE-09-0139, PubMed 19671706

Warren DJ, Nordlund MS, Paus E (2009)
Formulation of immunoassay calibrators in pasteurized albumin can significantly enhance their durability
J Immunol Methods, 353 (1-2), 145-7
DOI 10.1016/j.jim.2009.12.001, PubMed 20006616

Warren DJ, Nustad K, Beard JB, O'Brien TJ (2009)
Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop
Tumour Biol, 30 (2), 51-60
DOI 10.1159/000209988, PubMed 19321947

Publications 2008

Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ (2008)
Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study
Arch Intern Med, 168 (8), 855-60
DOI 10.1001/archinte.168.8.855, PubMed 18443261

Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K (2008)
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study
Scand J Clin Lab Invest, 68 (8), 703-13
DOI 10.1080/00365510802126836, PubMed 18609108

Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E (2008)
Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
Tumour Biol, 29 (3), 204-10
DOI 10.1159/000148188, PubMed 18667845

Nordlund MS, Warren DJ, Nustad K, Bjerner J, Paus E (2008)
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide
Clin Chem, 54 (5), 919-22
DOI 10.1373/clinchem.2007.101436, PubMed 18443179

Publications 2007

Asvold BO, Bjøro T, Nilsen TI, Vatten LJ (2007)
Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study
J Clin Endocrinol Metab, 92 (3), 841-5
DOI 10.1210/jc.2006-2208, PubMed 17200168

Asvold BO, Bjøro T, Nilsen TI, Vatten LJ (2007)
Tobacco smoking and thyroid function: a population-based study
Arch Intern Med, 167 (13), 1428-32
DOI 10.1001/archinte.167.13.1428, PubMed 17620538

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T (2007)
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study
Eur J Endocrinol, 156 (2), 181-6
DOI 10.1530/eje.1.02333, PubMed 17287407

Asvold BO, Vatten LJ, Nilsen TIL, Bjoro T (2007)
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study (vol 156, pg 181, 2007)
Eur. J. Endocrinol., 156 (6), 707
DOI 10.1530/eje.1.02333e

Brydøy M, Fosså SD, Dahl O, Bjøro T (2007)
Gonadal dysfunction and fertility problems in cancer survivors
Acta Oncol, 46 (4), 480-9
DOI 10.1080/02841860601166958, PubMed 17497315

Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, Dahl AA (2007)
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
Gynecol Oncol, 108 (2), 348-54
DOI 10.1016/j.ygyno.2007.10.009, PubMed 17996925

Nordlund MS, Fermer C, Nilsson O, Warren DJ, Paus E (2007)
Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP
Tumour Biol, 28 (2), 100-10
DOI 10.1159/000099335, PubMed 17287611

Sigstad E, Heilo A, Paus E, Holgersen K, Grøholt KK, Jørgensen LH, Bogsrud TV, Berner A, Bjøro T (2007)
The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay
Diagn Cytopathol, 35 (12), 761-7
DOI 10.1002/dc.20726, PubMed 18008339

Publications 2006

Andersen A, Warren DJ, Brunsvig PF, Aamdal S, Kristensen GB, Olsen H (2006)
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
BMC Clin Pharmacol, 6, 2
DOI 10.1186/1472-6904-6-2, PubMed 16412237

Haukvik UK, Dieset I, Bjøro T, Holte H, Fosså SD (2006)
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
Ann Oncol, 17 (9), 1428-33
DOI 10.1093/annonc/mdl149, PubMed 16831852

Hollender A, Bjøro T, Otto Karlsen K, Kvaloy SO, Nome O, Holte H (2006)
Vitamin D deficiency in patients operated on for gastric lymphoma
Scand J Gastroenterol, 41 (6), 673-81
DOI 10.1080/00365520500356510, PubMed 16716965

Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
Anticancer Res, 26 (3A), 1909-16
PubMed 16827124

Publications 2005

Engum A, Bjøro T, Mykletun A, Dahl AA (2005)
Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population
J Psychosom Res, 59 (5), 263-8
DOI 10.1016/j.jpsychores.2005.04.002, PubMed 16253615

Fosså SD, Holte H, Holmen MM, Bjøro T, Langmark F, Hess SL, Kvaløy S (2005)
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 125 (1), 41-4
PubMed 15643464

Hagen K, Bjøro T, Zwart JA, Svebak S, Bovim G, Stovner LJ (2005)
Do high TSH values protect against chronic musculoskeletal complaints? The Nord-Trøndelag Health Study (HUNT)
Pain, 113 (3), 416-421
DOI 10.1016/j.pain.2004.11.022, PubMed 15661451

Hinselwood DC, Warren DJ, Ekstrøm PO (2005)
High-throughput gender determination using automated denaturant gel capillary electrophoresis
Electrophoresis, 26 (13), 2562-6
DOI 10.1002/elps.200410392, PubMed 15934052

Nord C, Mykletun A, Thorsen L, Bjøro T, Fosså SD (2005)
Self-reported health and use of health care services in long-term cancer survivors
Int J Cancer, 114 (2), 307-16
DOI 10.1002/ijc.20713, PubMed 15543613

Warren DJ, Bjerner J, Paus E, Børmer OP, Nustad K (2005)
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies
Clin Chem, 51 (5), 830-8
DOI 10.1373/clinchem.2004.046979, PubMed 15718486

Yri OE, Bjoro T, Fossa SD (2005)
Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer
Eur Urol, 49 (1), 54-8; discussion 58
DOI 10.1016/j.eururo.2005.09.009, PubMed 16314038

Publications 2004

Cruciani V, Heintz KM, Husøy T, Hovig E, Warren DJ, Mikalsen SO (2004)
The detection of hamster connexins: a comparison of expression profiles with wild-type mouse and the cancer-prone Min mouse
Cell Commun Adhes, 11 (5-6), 155-71
DOI 10.1080/15419060500242877, PubMed 16194882

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E (2004)
Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis
Anal Chem, 76 (15), 4406-9
DOI 10.1021/ac049788k, PubMed 15283579

Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O, Andersson Y (2004)
Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
Radiother Oncol, 72 (3), 305-10
DOI 10.1016/j.radonc.2004.07.002, PubMed 15450729

Publications 2003

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930

Paus E, Almåsbak H, Børmer OP, Warren DJ (2003)
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
J Immunol Methods, 283 (1-2), 125-39
DOI 10.1016/j.jim.2003.08.018, PubMed 14659905

Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø (2003)
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Oncogene, 22 (55), 8952-5
DOI 10.1038/sj.onc.1207000, PubMed 14654792

Raastad T, Glomsheller T, Bjøro T, Hallén J (2003)
Recovery of skeletal muscle contractility and hormonal responses to strength exercise after two weeks of high-volume strength training
Scand J Med Sci Sports, 13 (3), 159-68
DOI 10.1034/j.1600-0838.2003.00297.x, PubMed 12753488

Publications 2002

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy
J Intern Med, 251 (5), 400-6
DOI 10.1046/j.1365-2796.2002.00974.x, PubMed 11982739

Engum A, Bjøro T, Mykletun A, Dahl AA (2002)
An association between depression, anxiety and thyroid function--a clinical fact or an artefact?
Acta Psychiatr Scand, 106 (1), 27-34
DOI 10.1034/j.1600-0447.2002.01250.x, PubMed 12100345

Fodstad P, Bjøro T, Torlakovic G, Fossa SD (2002)
No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer
J Urol, 168 (3), 1188-92
DOI 10.1016/S0022-5347(05)64623-X, PubMed 12187265

Publications 2001

Bjerke SN, Bjøro T, Heyerdahl S (2001)
[Psychiatric and cognitive aspects of hypothyroidism]
Tidsskr Nor Laegeforen, 121 (20), 2373-6
PubMed 11603044

Dajani LK, Paus E, Warren DJ (2001)
Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase A
Clin Chem, 47 (5), 867-73
PubMed 11325890

Hagen K, Bjøro T, Zwart JA, Vatten L, Stovner LJ, Bovim G (2001)
Low headache prevalence amongst women with high TSH values
Eur J Neurol, 8 (6), 693-9
DOI 10.1046/j.1468-1331.2001.00310.x, PubMed 11784355

Hovig E, Rye PD, Warren DJ, Nustad K (2001)
CA 125: the end of the beginning
Tumour Biol, 22 (6), 345-7
DOI 10.1159/000050637, PubMed 11786728

Johansen PW, Paulssen RH, Bjøro T, Gautvik KM, Gordeladze JO (2001)
Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation
Cell Physiol Biochem, 11 (6), 339-52
DOI 10.1159/000047820, PubMed 11832659

Lysaa RA, Warren DJ, Sylte I, Aarbakke J (2001)
Effect of the glutathione/glutathione disulfide redox couple on thiopurine methyltransferase
Biochem Pharmacol, 61 (6), 707-14
DOI 10.1016/s0006-2952(01)00528-7, PubMed 11266655

Raastad T, Glomsheller T, Bjøro T, Hallén J (2001)
Changes in human skeletal muscle contractility and hormone status during 2 weeks of heavy strength training
Eur J Appl Physiol, 84 (1-2), 54-63
DOI 10.1007/s004210000328, PubMed 11394254

Publications 2000

Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2000)
Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT)
Eur J Endocrinol, 143 (5), 639-47
DOI 10.1530/eje.0.1430639, PubMed 11078988

Ostberg BC, Sand O, Bjøro T, Haug E (2000)
Perfusion system for studying peptide secretion from endocrine cells with high time resolution
Biotechniques, 29 (5), 1114-8, 1120, 1122-5
DOI 10.2144/00295rr08, PubMed 11084875

Raastad T, Bjøro T, Hallén J (2000)
Hormonal responses to high- and moderate-intensity strength exercise
Eur J Appl Physiol, 82 (1-2), 121-8
DOI 10.1007/s004210050661, PubMed 10879453

Strømhaug A, Warren DJ (2000)
A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro
Cancer Chemother Pharmacol, 45 (6), 450-6
DOI 10.1007/s002800051018, PubMed 10854131

Publications 1999

Andersen A, Kasperlik-Zaluska AA, Warren DJ (1999)
Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography
Ther Drug Monit, 21 (3), 355-9
DOI 10.1097/00007691-199906000-00020, PubMed 10365653

Publications 1997

Bernstein R, Midtbø K, Urdal P, Mørkrid L, Smith G, Muller C, Bjøro T, Haug E (1997)
Serum N-terminal pro-atrial natriuretic factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism
Thyroid, 7 (3), 415-9
DOI 10.1089/thy.1997.7.415, PubMed 9226213

Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Bjøro T, Revhaug A (1997)
Both growth hormone and exogenous glutamine increase gastrointestinal glutamine uptake in trauma
Ann Surg, 225 (1), 97-102
DOI 10.1097/00000658-199701000-00011, PubMed 8998125

Publications 1996

Torjesen PA, Bjøro T (1996)
Antibodies against [125I] testosterone in patient's serum: a problem for the laboratory and the patient
Clin Chem, 42 (12), 2047-8
PubMed 8969653

Publications 1995

Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P (1995)
Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)
Scand J Clin Lab Invest, 55 (2), 139-47
DOI 10.3109/00365519509089606, PubMed 7667607

Mjaaland M, Unneberg K, Jenssen TG, Bjøro T, Lindal S, Revhaug A (1995)
Metabolic effects of two regimens of growth hormone given before operation in piglets
Eur J Surg, 161 (9), 639-46
PubMed 8541422

Publications 1994

Berg JP, Liane KM, Bjørhovde SB, Bjøro T, Torjesen PA, Haug E (1994)
Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells
J Steroid Biochem Mol Biol, 50 (3-4), 145-50
DOI 10.1016/0960-0760(94)90021-3, PubMed 8049143

Berg JP, Sandvik JA, Ree AH, Sørnes G, Bjøro T, Torjesen PA, Gordeladze JO, Haug E (1994)
1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha
Endocrinology, 135 (2), 595-602
DOI 10.1210/endo.135.2.8033808, PubMed 8033808

Sørnes S, Bjøro T, Berg JP, Torjesen PA, Haug E (1994)
Calcitriol attenuates the basal and vasoactive intestinal peptide-stimulated cAMP production in prolactin-secreting rat pituitary (GH4C1) cells
Mol Cell Endocrinol, 101 (1-2), 183-8
DOI 10.1016/0303-7207(94)90233-x, PubMed 9397951

Publications 1993

Bjøro T, Englund K, Torjesen PA, Haug E (1993)
Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells
Scand J Clin Lab Invest, 53 (2), 111-6
DOI 10.3109/00365519309088397, PubMed 8469910

Bjøro T, Johansen E, Frey HH, Turter A, Torjesen PA (1993)
Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin
Acta Endocrinol (Copenh), 128 (4), 308-12
DOI 10.1530/acta.0.1280308, PubMed 8498149

Kvistborg A, Halse J, Bakke S, Bjøro T, Hansen E, Djøseland O, Brownell J, Jervell J (1993)
Long-term treatment of macroprolactinomas with CV 205-502
Acta Endocrinol (Copenh), 128 (4), 301-7
DOI 10.1530/acta.0.1280301, PubMed 8098891

Mjaaland M, Unneberg K, Bjøro T, Revhaug A (1993)
Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition
Metabolism, 42 (2), 185-90
DOI 10.1016/0026-0495(93)90033-k, PubMed 8474315

Aanestad M, Røtnes JS, Torjesen PA, Haug E, Sand O, Bjøro T (1993)
Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium
Acta Endocrinol (Copenh), 128 (4), 361-6
DOI 10.1530/acta.0.1280361, PubMed 8388615

Publications 1992

Bjøro T, Larsen V, Englund K, Torjesen PA, Haug E (1992)
The lipoxygenase inhibitor nafazatrom inhibits stimulated prolactin secretion in cultured rat lactotrophs (GH4C1 cells)
Scand J Clin Lab Invest, 52 (4), 297-303
DOI 10.3109/00365519209088362, PubMed 1332181

Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992)
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus
Kidney Int, 41 (4), 920-3
DOI 10.1038/ki.1992.140, PubMed 1513113

Publications 1990

Bjøro T, Sand O, Ostberg BC, Gordeladze JO, Torjesen P, Gautvik KM, Haug E (1990)
The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells
Biosci Rep, 10 (2), 189-99
DOI 10.1007/BF01116578, PubMed 2162702

Jacobsen TF, Sand O, Bjøro T, Karlsen HE, Iversen JG (1990)
Effect of Diamphidia toxin, a Bushman arrow poison, on ionic permeability in nucleated cells
Toxicon, 28 (4), 435-44
DOI 10.1016/0041-0101(90)90082-i, PubMed 2161574

Tanbo T, Abyholm T, Bjøro T, Dale PO (1990)
Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders
Hum Reprod, 5 (7), 811-5
DOI 10.1093/oxfordjournals.humrep.a137188, PubMed 2125056

Publications 1989

Bjøro T, Frey HM, Larsen IF, Brochmann H, Hanson F, Gaarder PI (1989)
[Thyroid dysfunction and thyroid antibodies in a population group over the age of 70. A prevalence study from Oslo and Naeröy]
Tidsskr Nor Laegeforen, 109 (10), 1048-51
PubMed 2786266

Gordeladze JO, Björo T, Torjesen PA, Ostberg BC, Haug E, Gautvik KM (1989)
Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi
Eur J Biochem, 183 (2), 397-406
DOI 10.1111/j.1432-1033.1989.tb14941.x, PubMed 2569396

Sand O, Chen B, Li Q, Karlsen HE, Bjøro T, Haug E (1989)
Vasoactive intestinal peptide (VIP) may reduce the removal rate of cytosolic Ca2+ after transient elevations in clonal rat lactotrophs
Acta Physiol Scand, 137 (1), 113-23
DOI 10.1111/j.1748-1716.1989.tb08727.x, PubMed 2552748

Publications 1988

Bjøro T, Ostberg BC, Sand O, Torjesen PA, Penman E, Gordeladze JO, Iversen JG, Gautvik KM, Haug E (1988)
Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs
Acta Physiol Scand, 133 (3), 271-82
DOI 10.1111/j.1748-1716.1988.tb08408.x, PubMed 2906508

Brochmann H, Bjøro T, Gaarder PI, Hanson F, Frey HM (1988)
Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naerøy)
Acta Endocrinol (Copenh), 117 (1), 7-12
DOI 10.1530/acta.0.1170007, PubMed 3381628

Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaes O (1988)
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study
Acta Endocrinol (Copenh), 117 (1), 19-25
DOI 10.1530/acta.0.1170019, PubMed 3289293

Gordeladze JO, Bjøro T, Ostberg BC, Sand O, Torjesen P, Haug E, Gautvik KM (1988)
Phorbol esters and thyroliberin have distinct actions regarding stimulation of prolactin secretion and activation of adenylate cyclase in rat pituitary tumour cells (GH4C1 cells)
Biochem Pharmacol, 37 (16), 3133-8
DOI 10.1016/0006-2952(88)90311-5, PubMed 2900008

JORGENSEN KD, HANSSEN KF, KIERULF P, BJORO T, SANDVIK L, AAGENAES O (1988)
REDUCTION OF URINARY ALBUMIN EXCRETION AFTER 4 YEARS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN INSULIN-DEPENDENT DIABETES-MELLITUS - THE OSLO STUDY
Diabetes Metab., 14 (2BIS), 220-221

Torjesen PA, Bjøro T, Ostberg BC, Haug E (1988)
Thyrotropin-releasing hormone-stimulated inositol trisphosphate formation is liable to thyrotropin-releasing hormone-induced desensitization by a calcium-dependent mechanism
Mol Cell Endocrinol, 56 (1-2), 107-14
DOI 10.1016/0303-7207(88)90014-7, PubMed 3131167

Publications 1987

Bjøro T, Ostberg BC, Sand O, Gordeladze J, Iversen JG, Torjesen PA, Gautvik KM, Haug E (1987)
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+
Mol Cell Endocrinol, 49 (2-3), 119-28
DOI 10.1016/0303-7207(87)90205-x, PubMed 2435588

Bjøro T, Torjesen PA, Ostberg BC, Sand O, Iversen JG, Gautvik KM, Haug E (1987)
Bombesin stimulates prolactin secretion from cultured rat pituitary tumour cells (GH4C1) via activation of phospholipase C
Regul Pept, 19 (3-4), 169-82
DOI 10.1016/0167-0115(87)90274-6, PubMed 2829290

Bjøro T, Wiik P, Opstad PK, Gautvik KM, Haug E (1987)
Binding and degradation of vasoactive intestinal peptide in prolactin-producing cultured rat pituitary tumour cells (GH4C1)
Acta Physiol Scand, 130 (4), 609-18
DOI 10.1111/j.1748-1716.1987.tb08183.x, PubMed 2820199

Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjøro T, Pfeifer-Ohlsson S, Watt R, Funderud S, Godal T (1987)
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes
J Cell Physiol, 131 (3), 426-33
DOI 10.1002/jcp.1041310315, PubMed 3036888

Griffiths D, Bjøro T, Gautvik K, Haug E (1987)
Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture
Acta Physiol Scand, 131 (1), 43-9
DOI 10.1111/j.1748-1716.1987.tb08203.x, PubMed 2823532

Haug E, Bjøro T, Gautvik KM (1987)
A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells
J Steroid Biochem, 28 (4), 385-91
DOI 10.1016/0022-4731(87)91055-7, PubMed 2889849

Publications 1986

Ostberg BC, Sand O, Bjøro T, Haug E (1986)
The phorbol ester TPA induces hormone release and electrical activity in clonal rat pituitary cells
Acta Physiol Scand, 126 (4), 517-24
DOI 10.1111/j.1748-1716.1986.tb07850.x, PubMed 3087138

Publications 1984

Bjøro T, Gaarder PI, Smeland EB, Kornstad L (1984)
Thyroid antibodies in blood donors: prevalence and clinical significance
Acta Endocrinol (Copenh), 105 (3), 324-9
DOI 10.1530/acta.0.1050324, PubMed 6702401

Bjøro T, Haug E, Sand O, Gautvik KM (1984)
Vasoactive intestinal peptide causes a calcium-dependent stimulation of prolactin secretion in GH4C1 cells
Mol Cell Endocrinol, 37 (1), 41-50
DOI 10.1016/0303-7207(84)90126-6, PubMed 6432604

Publications 1982

Bjøro T (1982)
[Hemorrhaging corpus luteum. An important cause of acute abdomen in young women]
Tidsskr Nor Laegeforen, 102 (12), 681-3
PubMed 7157246